1996 FDA Approved Drugs

The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. Review descriptions for our medical therapeutic area list to help assist in your search.

Join our Drug Research Updates group on LinkedIn! 

Find out more about the types of drugs included in this listing.

Cardiology/Vascular Diseases

Covera-HS (verapamil); GD Searle, Alza; Treatment for hypertension and angina, Approved January 1996

Lipitor (atorvastatin calcium); Pfizer; For the prevention of cardiovascular disease and treatment of hyperlipidemia and dyslipidemia, Approved December 1996

Mavik (trandolapril); Knoll Pharmaceutical; Treatment for hypertension, Approved May 1996

Muse; Vivus; Treatment for impotence, Approved October 1996

Pravachol (pravastatin sodium); Bristol-Myers Squibb; Treatment for cholesterol-lowering, Approved July 1996

Pravachol (pravastatin sodium); Bristol-Myers Squibb; Treatment for heart disease, Approved April 1996

ProAmatine (midodrine); Roberts Pharmaceutical; Treatment for hypotension, Approved September 1996

Procanbid (procainamide hydrochloride extended-release tablets); Warner-Lambert; Treatment for ventricular arrhythmias, Approved January 1996

Retavase (reteplase); Boehringer Mannheim Corporation; Treatment for patients suffering from heart attack, Approved November 1996

Teczem (enalapril maleate/diltiazem malate); Hoechst Marion Roussel; Treatment for hypertension, Approved October 1996

Tiazac (diltiazem hydrochloride); Forest Laboratories; Treatment for hypertension, Approved February 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Dental and Oral Health

DentiPatch (lidocaine transoral delivery system); Noven Pharmaceuticals; Dental anesthetic patch, Approved May 1996

Dermatology

Differin (adapalene gel) Gel, 0.1%; Galderma Laboratories; Treatment for acne, Approved June 1996

Iamin; ProCyte; Gel wound dressing, Approved February 1996

Iontocaine; Iomed; Needle-free anesthetic, Approved May 1996

IvyBlock; EnviroDerm Pharmaceuticals; Treatment for poison ivy, poison oak, and poison sumac, Approved September 1996

Endocrinology

Aredia (pamidronate disodium for injection); Chiron; Treatment for osteolytic bone metastases of breast cancer, Approved August 1996

Arimidex (anastrozole); AstraZeneca; Treatment for advanced breast cancer in postmenopausal women, Approved January 1996

Azulfidine EN-tabs Tablets (sulfasalazine delayed release tablets, USP); Pharmacia & Upjohn; Treatment for rheumatoid arthritis, Approved October 1996

Campostar; Pharmacia & Upjohn; Treatment for metastatic colorectal cancer, Approved June 1996

CEA-Scan; Immunomedics; Diagnostic imaging product for colorectal cancer, Approved April 1996

Confide; Johnson & Johnson; HIV testing and counseling service, Approved May 1996

Covera-HS (verapamil); GD Searle, Alza; Treatment for hypertension and angina, Approved January 1996

Desmopressin Acetate (DDAVP); Rhone Poulenc Rorer; Treatment for central diabetes insipidus, Approved February 1996

Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection); Orphan Medical; Treatment of meningeal leukemia or lymphocytic lymphoma, Approved October 1996

Estrostep (norethindrone acetate and ethinyl estradiol); Parke-Davis; Treatment for birth control, Approved October 1996

Eulexin (flutamide); Schering-Plough; Treatment for prostate cancer, Approved June 1996

FemPatch; Parke-Davis; Treatment for menopausal symptoms, Approved December 1996

Fertinex (urofollitropin for injection, purified); Serono Laboratories; Treatment for patients undergoing infertility treatments, Approved September 1996

Gemzar (gemcitabine HCL); Eli Lilly; Treatment for pancreatic cancer, Approved May 1996

Glyset (miglitol); Bayer; Treatment for Type II (non-insulin-dependent) diabetes mellitus, Approved December 1996

Humalog (insulin lispro); Eli Lilly; Treatment for type I and type II diabetes, Approved June 1996

Humatrope (somatropin [rDNA origin] for injection); Eli Lilly; Treatment for Somatropin Deficiency Syndrome, Approved August 1996

Hycamtin (topotecan hydrochloride); SmithKline Beecham; Treatment for metastatic ovarian cancer, Approved May 1996

Lithobid (Lithium Carbonate); Solvay Pharmaceuticals; Treatment for manic depression, Approved January 1996

Lodine (etodolac); Wyeth; Treatment for rheumatoid arthritis, Approved July 1996

Lupron Depot (leuprolide acetate for depot suspension); Abbott Laboratories; Treatment for advanced prostate cancer, Approved January 1996

Mavik (trandolapril); Knoll Pharmaceutical; Treatment for hypertension, Approved May 1996

Naprelan (naproxen sodium); Elan Pharmaceuticals, Wyeth; Treatment for osteoarthritis and rheumatoid arthritis, Approved January 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Nutropin (somatropin-rDNA origin); Genentech; Treatment that consists of recombinant growth hormone product, Approved January 1996

OxyContin (oxycodone HCl controlled-release); Purdue Pharma; Treatment for pain associated with musculoskeletal conditions, Approved May 1996

Pravachol (pravastatin sodium); Bristol-Myers Squibb; Treatment for cholesterol-lowering, Approved July 1996

Redux (dexfenfluramine hydrochloride); Wyeth; Treatment for obesity, Approved May 1996

Remeron (Mirtazapine); Organon; Treatment for depression, Approved June 1996

Saizen; Ares-Serono; Treatment for growth hormone deficiency and Turner Syndrome, Approved May 1996

Taxotere (Docetaxel); Rhone Poulenc Rorer; Treatment for locally advanced or metastatic breast cancer, Approved May 1996

Teczem (enalapril maleate/diltiazem malate); Hoechst Marion Roussel; Treatment for hypertension, Approved October 1996

Tiazac (diltiazem hydrochloride); Forest Laboratories; Treatment for hypertension, Approved February 1996

Vivelle (estradiol transdermal system); Ciba Pharmaceuticals; Treatment for moderate and severe vasomotor menopausal symptoms, Approved March 1996

Zoladex (10.8 mg goserelin acetate implant); AstraZeneca; Treatment for advanced prostate cancer, Approved January 1996

Family Medicine

Accolate; AstraZeneca; Treatment for asthma, Approved October 1996

Adderall (mixed salts of a single-entity amphetamine); Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder, Supplemental NDA Approved February 1996

Alphagan (brimonidine); Allergan; Treatment for open-angle glaucoma and ocular hypertension, Approved September 1996

Anexsia; Mallinckrodt Group; Treatment for chronic pain, Approved August 1996

Apthasol (Amlexanox); Access Pharmaceuticals; Treatment for canker sores, Approved May 1996

Aredia (pamidronate disodium for injection); Chiron; Treatment for osteolytic bone metastases of breast cancer, Approved August 1996

ARICEPT (donepezil hydrochloride); Eisai; Treatment for Alzheimer's Disease, Approved December 1996

Arimidex (anastrozole); AstraZeneca; Treatment for advanced breast cancer in postmenopausal women, Approved January 1996

Atrovent (ipratropium bromide); Boehringer Ingelheim; Treatment for runny nose due to allergies and the common cold, Approved January 1996

Augmentin (amoxicillin/clavulanate); SmithKline Beecham; Treatment for infections involving drug-resistant bacteria, Approved February 1996

Axid AR (nizatidine; Whitehall-Robins Healthcare; Over-the-counter anti-ulcer treatment, Approved May 1996

Azmacort (triamcinolone acetonide) Inhalation Aerosol; Rhone Poulenc Rorer; Treatment for asthma, Approved November 1996

Azulfidine EN-tabs Tablets (sulfasalazine delayed release tablets, USP); Pharmacia & Upjohn; Treatment for rheumatoid arthritis, Approved October 1996

Campostar; Pharmacia & Upjohn; Treatment for metastatic colorectal cancer, Approved June 1996

Carrington patch; Carrington Laboratories; Treatment for canker sores, Approved May 1996

CEA-Scan; Immunomedics; Diagnostic imaging product for colorectal cancer, Approved April 1996

Children's Advil (pediatric ibuprofen); Whitehall-Robins Healthcare; Treatment of fever and minor aches and pains, Approved July 1996

Claritin Syrup (loratadine); Schering-Plough; Treatment for children with seasonal allergies, Approved October 1996

Confide; Johnson & Johnson; HIV testing and counseling service, Approved May 1996

Crixivan (Indinavir sulfate); Merck; Treatment for HIV infection, Approved March 1996

DentiPatch (lidocaine transoral delivery system); Noven Pharmaceuticals; Dental anesthetic patch, Approved May 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for epilepsy, Approved June 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for migraine headaches, Approved March 1996

Differin (adapalene gel) Gel, 0.1%; Galderma Laboratories; Treatment for acne, Approved June 1996

Elmiron (pentosan polysulfate sodium); IVAX; Treatment for interstitial cystitis, Approved October 1996

Eulexin (flutamide); Schering-Plough; Treatment for prostate cancer, Approved June 1996

FemPatch; Parke-Davis; Treatment for menopausal symptoms, Approved December 1996

Feridex I.V.; Advanced Magnetics; Contrast agent for magnetic resonance imaging of liver lesions, Approved February 1996

Fertinex (urofollitropin for injection, purified); Serono Laboratories; Treatment for patients undergoing infertility treatments, Approved September 1996

Gastrocrom Oral Concentrate (cromolyn sodium); Rhone Poulenc Rorer; Treatment for mastocytosis, Approved April 1996

GastroMARK; Advanced Magnetics; Contrast agent for magnetic resonance imaging of the gastrointestinal tract, Approved May 1996

Gemzar (gemcitabine HCL); Eli Lilly; Treatment for pancreatic cancer, Approved May 1996

Glyset (miglitol); Bayer; Treatment for Type II (non-insulin-dependent) diabetes mellitus, Approved December 1996

Humalog (insulin lispro); Eli Lilly; Treatment for type I and type II diabetes, Approved June 1996

Hycamtin (topotecan hydrochloride); SmithKline Beecham; Treatment for metastatic ovarian cancer, Approved May 1996

Kadian; Purepac Pharmaceutical; Treatment for chronic moderate to severe pain, Approved July 1996

Lamisil (terbinafine hydrochloride) Tablets; Sandoz Pharmaceuticals; Treatment for nail fungal infections, Approved May 1996

Leukine (sargramostim); Immunex; Treatment for the replenishment of white blood cells, Approved November 1996

Lithobid (Lithium Carbonate); Solvay Pharmaceuticals; Treatment for manic depression, Approved January 1996

Lodine (etodolac); Wyeth; Treatment for rheumatoid arthritis, Approved July 1996

Lupron Depot (leuprolide acetate for depot suspension); Abbott Laboratories; Treatment for advanced prostate cancer, Approved January 1996

Mavik (trandolapril); Knoll Pharmaceutical; Treatment for hypertension, Approved May 1996

Monistat 3 (miconazole nitrate); Johnson & Johnson; Over the counter treatment for vaginal yeast infections, Approved April 1996

Monurol; Forest Laboratories; Treatment for uncomplicated urinary tract infection, Approved December 1996

Muse; Vivus; Treatment for impotence, Approved October 1996

Naprelan (naproxen sodium); Elan Pharmaceuticals, Wyeth; Treatment for osteoarthritis and rheumatoid arthritis, Approved January 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Ocuflox (ofloxacin opthalmic solution) 0.3%; Allergan; Treatment for corneal ulcers, Approved May 1996

OcuHist; Pfizer; Over-the-counter antihistamine eye drop, Approved January 1996

Oral Cytovene; Roche; Treatment for the prevention of cytomegalovirus (CMV), Approved December 1996

OxyContin (oxycodone HCl controlled-release); Purdue Pharma; Treatment for pain associated with musculoskeletal conditions, Approved May 1996

Paxil (paroxetine hydrochloride); SmithKline Beecham; Treatment for panic disorder, Approved May 1996

Photodynamic Therapy; Sanofi-aventis; Photodynamic therapy device for the treatment of esophageal cancer, Approved January, 1996

Pravachol (pravastatin sodium); Bristol-Myers Squibb; Treatment for heart disease, Approved April 1996

Pravachol (pravastatin sodium); Bristol-Myers Squibb; Treatment for cholesterol-lowering, Approved July 1996

Prilosec (omeprazole); Astra Merck; Treatment for gastric ulcers, Approved March 1996

Prilosec (omeprazole); Astra Merck; Treatment for heartburn, gastroesophageal reflux disease (GERD), Approved December 1996

Prilosec (omeprazole)/Biaxin (clarithromycin) Combination Therapy; Astra Merck, Abbott Laboratories; Treatment for duodenal ulcers, Approved April 1996

ProAmatine (midodrine); Roberts Pharmaceutical; Treatment for hypotension, Approved September 1996

Procanbid (procainamide hydrochloride extended-release tablets); Warner-Lambert; Treatment for ventricular arrhythmias, Approved January 1996

Remeron (Mirtazapine); Organon; Treatment for depression, Approved June 1996

RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous); MedImmune; Treatment for the prevention of respiratory syncytial virus disease, Approved January 1996

Retavase (reteplase); Boehringer Mannheim Corporation; Treatment for patients suffering from heart attack, Approved November 1996

Tavist (clemastine fumarate); Sandoz Pharmaceuticals; Treatment for cold symptoms, Approved November 1996

Taxotere (Docetaxel); Rhone Poulenc Rorer; Treatment for locally advanced or metastatic breast cancer, Approved May 1996

Teczem (enalapril maleate/diltiazem malate); Hoechst Marion Roussel; Treatment for hypertension, Approved October 1996

Tegretol (carbamazepine); Ciba Pharmaceuticals; Treatment for young children with epilepsy, Approved March 1996

Tegretol XR (carbamazepine); Ciba-Geigy; Anti-epileptic treatment, Approved May 1996

Tiazac (diltiazem hydrochloride); Forest Laboratories; Treatment for hypertension, Approved February 1996

UltraJect; Mallinckrodt Group; Treatment for chronic pain, Approved August 1996

Videx (didanosine); Bristol-Myers Squibb; Treatment of HIV infection, Approved June 1996

Viramune (nevirapine); Boehringer Ingelheim; Treatment for HIV infection, Approved June 1996

Vistide (cidofovir); Gilead; Treatment for cytomegalovirus (CMV) retinitis, Approved June 1996

Vitrasert Implant; Chiron; Drug delivery system for the treatment of cytomegalovirus, Approved March 1996

Vivelle (estradiol transdermal system); Ciba Pharmaceuticals; Treatment for moderate and severe vasomotor menopausal symptoms, Approved March 1996

Zoladex (10.8 mg goserelin acetate implant); AstraZeneca; Treatment for advanced prostate cancer, Approved January 1996

Gastroenterology

Axid AR (nizatidine; Whitehall-Robins Healthcare; Over-the-counter anti-ulcer treatment, Approved May 1996

Cipro (ciprofloxacin) I.V. and Cipro (ciprofloxacin HCI) tablets; Bayer; Treatment for complicated intra-abdominal infections, Approved December 1996

GastroMARK; Advanced Magnetics; Contrast agent for magnetic resonance imaging of the gastrointestinal tract, Approved May 1996

Merrem I.V. (meropenem); AstraZeneca; Treatment for intra-abdominal infections and bacterial meningitis, Approved June 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Prilosec (omeprazole); Astra Merck; Treatment for heartburn, gastroesophageal reflux disease (GERD), Approved December 1996

Prilosec (omeprazole); Astra Merck; Treatment for gastric ulcers, Approved March 1996

Prilosec (omeprazole)/Biaxin (clarithromycin) Combination Therapy; Astra Merck, Abbott Laboratories; Treatment for duodenal ulcers, Approved April 1996

Seprafilm; Genzyme; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery, Approved August 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Genetic Disease

AlphaNine SD Coagulation Factor IX (Human); Alpha Therapeutic Corporation; Treatment for the prevention and control of bleeding in subjects with hemophilia, Approved July 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for epilepsy, Approved June 1996

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis patients with advanced disease, Approved December 1996

Saizen; Ares-Serono; Treatment for growth hormone deficiency and Turner Syndrome, Approved May 1996

Tegretol (carbamazepine); Ciba Pharmaceuticals; Treatment for young children with epilepsy, Approved March 1996

Tegretol XR (carbamazepine); Ciba-Geigy; Anti-epileptic treatment, Approved May 1996

Hematology

AlphaNine SD Coagulation Factor IX (Human); Alpha Therapeutic Corporation; Treatment for the prevention and control of bleeding in subjects with hemophilia, Approved July 1996

Gastrocrom Oral Concentrate (cromolyn sodium); Rhone Poulenc Rorer; Treatment for mastocytosis, Approved April 1996

Leukine (sargramostim); Immunex; Treatment for the replenishment of white blood cells, Approved November 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Pravachol (pravastatin sodium); Bristol-Myers Squibb; Treatment for cholesterol-lowering, Approved July 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Hepatology (Liver, Pancreatic, Gall Bladder)

Feridex I.V.; Advanced Magnetics; Contrast agent for magnetic resonance imaging of liver lesions, Approved February 1996

Havrix; SmithKline Beecham; Treatment for hepatitis A, Approved March 1996

Prilosec (omeprazole); Astra Merck; Treatment for gastric ulcers, Approved March 1996

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis patients with advanced disease, Approved December 1996

Zithromax (azithromycin); Pfizer; Treatment for Mycobacterium avium complex (MAC) in subjects with advanced HIV infection, Approved June 1996

Immunology

Albenza (albendazole); SmithKline Beecham; Treatment for parasitic infections caused by worms, Approved June 1996

Apthasol (Amlexanox); Access Pharmaceuticals; Treatment for canker sores, Approved May 1996

Carrington patch; Carrington Laboratories; Treatment for canker sores, Approved May 1996

Confide; Johnson & Johnson; HIV testing and counseling service, Approved May 1996

Crixivan (Indinavir sulfate); Merck; Treatment for HIV infection, Approved March 1996

Gastrocrom Oral Concentrate (cromolyn sodium); Rhone Poulenc Rorer; Treatment for mastocytosis, Approved April 1996

Havrix; SmithKline Beecham; Treatment for hepatitis A, Approved March 1996

Lamisil (terbinafine hydrochloride) Tablets; Sandoz Pharmaceuticals; Treatment for nail fungal infections, Approved May 1996

Leukine (sargramostim); Immunex; Treatment for the replenishment of white blood cells, Approved November 1996

Oral Cytovene; Roche; Treatment for the prevention of cytomegalovirus (CMV), Approved December 1996

RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous); MedImmune; Treatment for the prevention of respiratory syncytial virus disease, Approved January 1996

Videx (didanosine); Bristol-Myers Squibb; Treatment of HIV infection, Approved June 1996

Viramune (nevirapine); Boehringer Ingelheim; Treatment for HIV infection, Approved June 1996

Vistide (cidofovir); Gilead; Treatment for cytomegalovirus (CMV) retinitis, Approved June 1996

Vitrasert Implant; Chiron; Drug delivery system for the treatment of cytomegalovirus, Approved March 1996

Zithromax (azithromycin); Pfizer; Treatment for Mycobacterium avium complex (MAC) in subjects with advanced HIV infection, Approved June 1996

Infections and Infectious Diseases

AK-Con-A (naphazoline ophthalmic); Akorn; Over-the-counter combination vasoconstrictor/antihistamine product for opthalmic use, Approved January 1996

Allegra (fexofenadine hydrochloride); Hoechst Marion Roussel; Treatment for seasonal allergy symptoms, Approved July 1996

Astelin nasal spray; Wallace Laboratories; Treatment for seasonal allergic rhinitis, Approved November 1996

Atrovent (ipratropium bromide); Boehringer Ingelheim; Treatment for runny nose due to allergies and the common cold, Approved January 1996

Augmentin (amoxicillin/clavulanate); SmithKline Beecham; Treatment for infections involving drug-resistant bacteria, Approved February 1996

Children's Advil (pediatric ibuprofen); Whitehall-Robins Healthcare; Treatment of fever and minor aches and pains, Approved July 1996

Confide; Johnson & Johnson; HIV testing and counseling service, Approved May 1996

Crixivan (Indinavir sulfate); Merck; Treatment for HIV infection, Approved March 1996

Elmiron (pentosan polysulfate sodium); IVAX; Treatment for interstitial cystitis, Approved October 1996

Havrix; SmithKline Beecham; Treatment for hepatitis A, Approved March 1996

IvyBlock; EnviroDerm Pharmaceuticals; Treatment for poison ivy, poison oak, and poison sumac, Approved September 1996

Lamisil (terbinafine hydrochloride) Tablets; Sandoz Pharmaceuticals; Treatment for nail fungal infections, Approved May 1996

Leukine (sargramostim); Immunex; Treatment for the replenishment of white blood cells, Approved November 1996

Merrem I.V. (meropenem); AstraZeneca; Treatment for intra-abdominal infections and bacterial meningitis, Approved June 1996

Nasacort AQ (triamcinolone acetonide) Nasal Spray; Rhone Poulenc Rorer; Treatment for allergic rhinitis, Approved May 1996

OcuHist; Pfizer; Over-the-counter antihistamine eye drop, Approved January 1996

RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous); MedImmune; Treatment for the prevention of respiratory syncytial virus disease, Approved January 1996

Tavist (clemastine fumarate); Sandoz Pharmaceuticals; Treatment for cold symptoms, Approved November 1996

Vancenase AQ 84 mcg Double Strength; Schering-Plough; Treatment for allergic and non-allergic rhinitis, Approved June 1996

Videx (didanosine); Bristol-Myers Squibb; Treatment of HIV infection, Approved June 1996

Viramune (nevirapine); Boehringer Ingelheim; Treatment for HIV infection, Approved June 1996

Zithromax (azithromycin); Pfizer; Treatment for Mycobacterium avium complex (MAC) in subjects with advanced HIV infection, Approved June 1996

Musculoskeletal

Kadian; Purepac Pharmaceutical; Treatment for chronic moderate to severe pain, Approved July 1996

Naprelan (naproxen sodium); Elan Pharmaceuticals, Wyeth; Treatment for osteoarthritis and rheumatoid arthritis, Approved January 1996

OxyContin (oxycodone HCl controlled-release); Purdue Pharma; Treatment for pain associated with musculoskeletal conditions, Approved May 1996

Saizen; Ares-Serono; Treatment for growth hormone deficiency and Turner Syndrome, Approved May 1996

Seprafilm; Genzyme; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery, Approved August 1996

Zanaflex (tizanidine hydrochloride); Elan Pharmaceuticals; Treatment for muscle spasticity, Approved December 1996

Nephrology

Cipro (ciprofloxacin HCl); Bayer; Treatment for cystitis, Approved April 1996

Elmiron (pentosan polysulfate sodium); IVAX; Treatment for interstitial cystitis, Approved October 1996

Eulexin (flutamide); Schering-Plough; Treatment for prostate cancer, Approved June 1996

Gemzar (gemcitabine HCL); Eli Lilly; Treatment for pancreatic cancer, Approved May 1996

Lupron Depot (leuprolide acetate for depot suspension); Abbott Laboratories; Treatment for advanced prostate cancer, Approved January 1996

Monurol; Forest Laboratories; Treatment for uncomplicated urinary tract infection, Approved December 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Seprafilm; Genzyme; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery, Approved August 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Zoladex (10.8 mg goserelin acetate implant); AstraZeneca; Treatment for advanced prostate cancer, Approved January 1996

Neurology

Anexsia; Mallinckrodt Group; Treatment for chronic pain, Approved August 1996

ARICEPT (donepezil hydrochloride); Eisai; Treatment for Alzheimer's Disease, Approved December 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for epilepsy, Approved June 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for migraine headaches, Approved March 1996

Iontocaine; Iomed; Needle-free anesthetic, Approved May 1996

Kadian; Purepac Pharmaceutical; Treatment for chronic moderate to severe pain, Approved July 1996

Merrem I.V. (meropenem); AstraZeneca; Treatment for intra-abdominal infections and bacterial meningitis, Approved June 1996

Redux (dexfenfluramine hydrochloride); Wyeth; Treatment for obesity, Approved May 1996

Tegretol (carbamazepine); Ciba Pharmaceuticals; Treatment for young children with epilepsy, Approved March 1996

Tegretol XR (carbamazepine); Ciba-Geigy; Anti-epileptic treatment, Approved May 1996

UltraJect; Mallinckrodt Group; Treatment for chronic pain, Approved August 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Zanaflex (tizanidine hydrochloride); Elan Pharmaceuticals; Treatment for muscle spasticity, Approved December 1996

Nutrition and Weight Loss

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Redux (dexfenfluramine hydrochloride); Wyeth; Treatment for obesity, Approved May 1996

Obstetrics/Gynecology (Women’s Health)

Aredia (pamidronate disodium for injection); Chiron; Treatment for osteolytic bone metastases of breast cancer, Approved August 1996

Arimidex (anastrozole); AstraZeneca; Treatment for advanced breast cancer in postmenopausal women, Approved January 1996

Estrostep (norethindrone acetate and ethinyl estradiol); Parke-Davis; Treatment for birth control, Approved October 1996

FemPatch; Parke-Davis; Treatment for menopausal symptoms, Approved December 1996

Fertinex (urofollitropin for injection, purified); Serono Laboratories; Treatment for patients undergoing infertility treatments, Approved September 1996

Hycamtin (topotecan hydrochloride); SmithKline Beecham; Treatment for metastatic ovarian cancer, Approved May 1996

Monistat 3 (miconazole nitrate); Johnson & Johnson; Over the counter treatment for vaginal yeast infections, Approved April 1996

Seprafilm; Genzyme; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery, Approved August 1996

Taxotere (Docetaxel); Rhone Poulenc Rorer; Treatment for locally advanced or metastatic breast cancer, Approved May 1996

Vivelle (estradiol transdermal system); Ciba Pharmaceuticals; Treatment for moderate and severe vasomotor menopausal symptoms, Approved March 1996

Oncology

Anexsia; Mallinckrodt Group; Treatment for chronic pain, Approved August 1996

Aredia (pamidronate disodium for injection); Chiron; Treatment for osteolytic bone metastases of breast cancer, Approved August 1996

Arimidex (anastrozole); AstraZeneca; Treatment for advanced breast cancer in postmenopausal women, Approved January 1996

Campostar; Pharmacia & Upjohn; Treatment for metastatic colorectal cancer, Approved June 1996

CEA-Scan; Immunomedics; Diagnostic imaging product for colorectal cancer, Approved April 1996

Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection); Orphan Medical; Treatment of meningeal leukemia or lymphocytic lymphoma, Approved October 1996

Eulexin (flutamide); Schering-Plough; Treatment for prostate cancer, Approved June 1996

Feridex I.V.; Advanced Magnetics; Contrast agent for magnetic resonance imaging of liver lesions, Approved February 1996

GastroMARK; Advanced Magnetics; Contrast agent for magnetic resonance imaging of the gastrointestinal tract, Approved May 1996

Gemzar (gemcitabine HCL); Eli Lilly; Treatment for pancreatic cancer, Approved May 1996

Hycamtin (topotecan hydrochloride); SmithKline Beecham; Treatment for metastatic ovarian cancer, Approved May 1996

Kadian; Purepac Pharmaceutical; Treatment for chronic moderate to severe pain, Approved July 1996

Leukine (sargramostim); Immunex; Treatment for the replenishment of white blood cells, Approved November 1996

Lupron Depot (leuprolide acetate for depot suspension); Abbott Laboratories; Treatment for advanced prostate cancer, Approved January 1996

Photodynamic Therapy; Sanofi-aventis; Photodynamic therapy device for the treatment of esophageal cancer, Approved January, 1996

Taxotere (Docetaxel); Rhone Poulenc Rorer; Treatment for locally advanced or metastatic breast cancer, Approved May 1996

UltraJect; Mallinckrodt Group; Treatment for chronic pain, Approved August 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Zoladex (10.8 mg goserelin acetate implant); AstraZeneca; Treatment for advanced prostate cancer, Approved January 1996

Ophthalmology

AK-Con-A (naphazoline ophthalmic); Akorn; Over-the-counter combination vasoconstrictor/antihistamine product for opthalmic use, Approved January 1996

Alphagan (brimonidine); Allergan; Treatment for open-angle glaucoma and ocular hypertension, Approved September 1996

Ocuflox (ofloxacin opthalmic solution) 0.3%; Allergan; Treatment for corneal ulcers, Approved May 1996

OcuHist; Pfizer; Over-the-counter antihistamine eye drop, Approved January 1996

Vistide (cidofovir); Gilead; Treatment for cytomegalovirus (CMV) retinitis, Approved June 1996

Vitrasert Implant; Chiron; Drug delivery system for the treatment of cytomegalovirus, Approved March 1996

Otolaryngology (Ear, Nose, Throat)

Bactroban Nasal 2% (mupirocin calcium ointment); SmithKline Beecham; Treatment for nasal bacteria, Approved April 1996

Pediatrics/Neonatology

Adderall (mixed salts of a single-entity amphetamine); Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder, Supplemental NDA Approved February 1996

Children's Advil (pediatric ibuprofen); Whitehall-Robins Healthcare; Treatment of fever and minor aches and pains, Approved July 1996

Claritin Syrup (loratadine); Schering-Plough; Treatment for children with seasonal allergies, Approved October 1996

Havrix; SmithKline Beecham; Treatment for hepatitis A, Approved March 1996

Merrem I.V. (meropenem); AstraZeneca; Treatment for intra-abdominal infections and bacterial meningitis, Approved June 1996

RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous); MedImmune; Treatment for the prevention of respiratory syncytial virus disease, Approved January 1996

Tegretol (carbamazepine); Ciba Pharmaceuticals; Treatment for young children with epilepsy, Approved March 1996

Tripedia (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed); Connaught Laboratories; Treatment for whooping cough, Approved August 1996

Pharmacology/Toxicology

Iontocaine; Iomed; Needle-free anesthetic, Approved May 1996

Lamisil (terbinafine hydrochloride) Tablets; Sandoz Pharmaceuticals; Treatment for nail fungal infections, Approved May 1996

Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996

Psychiatry/Psychology

Adderall (mixed salts of a single-entity amphetamine); Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder, Supplemental NDA Approved February 1996

ARICEPT (donepezil hydrochloride); Eisai; Treatment for Alzheimer's Disease, Approved December 1996

Depakote (divalproex sodium); Abbott Laboratories; Treatment for migraine headaches, Approved March 1996

Lithobid (Lithium Carbonate); Solvay Pharmaceuticals; Treatment for manic depression, Approved January 1996

NicoDerm CQ; SmithKline Beecham, Hoechst Marion Roussel, Alza; Treatment for smoking cessation, Approved August 1996

Nicorette (nicotine polacrilex); SmithKline Beecham; Over-the-counter aid in smoking cessation, Approved February 1996

Nicotrol nasal spray; Pharmacia & Upjohn; Treatment for nicotine addiction, Approved March 1996

Nicotrol transdermal patch; McNeil Consumer Products; Treatment for smoking cessation, Approved July 1996

Paxil (paroxetine hydrochloride); SmithKline Beecham; Treatment for panic disorder, Approved May 1996

Redux (dexfenfluramine hydrochloride); Wyeth; Treatment for obesity, Approved May 1996

Remeron (Mirtazapine); Organon; Treatment for depression, Approved June 1996

Risperdal Oral Formulation; Janssen Pharmaceuticals; Treatment for schizophrenia, Approved July 1996

Zyprexa; Eli Lilly; Treatment of the symptoms of psychotic disorders, Approved September 1996

Pulmonary/Respiratory Diseases

Accolate; AstraZeneca; Treatment for asthma, Approved October 1996

Allegra (fexofenadine hydrochloride); Hoechst Marion Roussel; Treatment for seasonal allergy symptoms, Approved July 1996

Astelin nasal spray; Wallace Laboratories; Treatment for seasonal allergic rhinitis, Approved November 1996

Atrovent (ipratropium bromide); Boehringer Ingelheim; Treatment for runny nose due to allergies and the common cold, Approved January 1996

Augmentin (amoxicillin/clavulanate); SmithKline Beecham; Treatment for infections involving drug-resistant bacteria, Approved February 1996

Azmacort (triamcinolone acetonide) Inhalation Aerosol; Rhone Poulenc Rorer; Treatment for asthma, Approved November 1996

Breathe Right; CNS; Treatment for breathing difficulties due to deviated nasal septum, Approved June 1996

Claritin Syrup (loratadine); Schering-Plough; Treatment for children with seasonal allergies, Approved October 1996

Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate); Schering-Plough; Treatment for nasal congestion, Approved August 1996

Covera-HS (verapamil); GD Searle, Alza; Treatment for hypertension and angina, Approved January 1996

Nasacort AQ (triamcinolone acetonide) Nasal Spray; Rhone Poulenc Rorer; Treatment for allergic rhinitis, Approved May 1996

OcuHist; Pfizer; Over-the-counter antihistamine eye drop, Approved January 1996

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis patients with advanced disease, Approved December 1996

RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous); MedImmune; Treatment for the prevention of respiratory syncytial virus disease, Approved January 1996

Tavist (clemastine fumarate); Sandoz Pharmaceuticals; Treatment for cold symptoms, Approved November 1996

Tripedia (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed); Connaught Laboratories; Treatment for whooping cough, Approved August 1996

Vancenase AQ 84 mcg Double Strength; Schering-Plough; Treatment for allergic and non-allergic rhinitis, Approved June 1996

Visipaque (iodixanol); Nycomed; Diagnostic contrast agent, Approved April 1996

Zosyn (sterile piperacillin sodium/tazobactam sodium); Wyeth; Treatment for hospital-acquired pneumonia, Approved May 1996

Rheumatology

Azulfidine EN-tabs Tablets (sulfasalazine delayed release tablets, USP); Pharmacia & Upjohn; Treatment for rheumatoid arthritis, Approved October 1996

Lodine (etodolac); Wyeth; Treatment for rheumatoid arthritis, Approved July 1996

Naprelan (naproxen sodium); Elan Pharmaceuticals, Wyeth; Treatment for osteoarthritis and rheumatoid arthritis, Approved January 1996

Trauma (Emergency, Injury, Surgery)

Iamin; ProCyte; Gel wound dressing, Approved February 1996

OsmoCyte Pillow Wound Dressing; ProCyte; Treatment for chronic and acute wounds, Approved December 1996

Urology

Eulexin (flutamide); Schering-Plough; Treatment for prostate cancer, Approved June 1996

Fertinex (urofollitropin for injection, purified); Serono Laboratories; Treatment for patients undergoing infertility treatments, Approved September 1996

Lupron Depot (leuprolide acetate for depot suspension); Abbott Laboratories; Treatment for advanced prostate cancer, Approved January 1996

Monurol; Forest Laboratories; Treatment for uncomplicated urinary tract infection, Approved December 1996

Muse; Vivus; Treatment for impotence, Approved October 1996

Zoladex (10.8 mg goserelin acetate implant); AstraZeneca; Treatment for advanced prostate cancer, Approved January 1996

Vaccines

Augmentin (amoxicillin/clavulanate); SmithKline Beecham; Treatment for infections involving drug-resistant bacteria, Approved February 1996

Havrix; SmithKline Beecham; Treatment for hepatitis A, Approved March 1996

Merrem I.V. (meropenem); AstraZeneca; Treatment for intra-abdominal infections and bacterial meningitis, Approved June 1996

Tripedia (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed); Connaught Laboratories; Treatment for whooping cough, Approved August 1996

Zosyn (sterile piperacillin sodium/tazobactam sodium); Wyeth; Treatment for hospital-acquired pneumonia, Approved May 1996